Glorious History OF XJPHARMA PRODUCTS

Products including Prednisolone were developed successfully in 1986.

Products including Norfloxacin and Medroxy Progesterone Acetate were developed successfully in 1988.

Trlanclnolone Acefonalde Acetate was developed successfully in 1989.

With the cooperation of Chinese Pharmaceutical University, Xjpharma developed the anti-early-pregnancy drug “Mifepristone”in 1990.

The annual production yield increased to 500kg by conducting technological innovation of the mifepristone process in 1994. This process innovation was awarded as “’85’ excellent project of technological innovation”by Project & Economy Committee of Zhejiang Province on April 10 , 1997.

On January 28 1997, Mifepristone tablets, Prednisone Acetate , and Norfloxacin (belonging to “Xianle” series products) were evaluated as “Famous Brand Products of Taizhou District”by the Evaluation Committee of Taizhou District. What’s more, HAN ZHU TING”(mifepristone tablets) was evaluated as “Famous Brand Products of Zhejiang Province” by the government of Zhejiang Province.

On March 3 1997, the APIs of Norfloxacin and naproxen won the title of " High Quality Drugs " , of which the certificate of honor and the certificate of merit were issued by the Pharmaceutical Administration Bureau of Zhejiang Province.

The project of Mifepristone, which was manufactured at an annual yield of 500 kg, and its process innovation was awarded as “’85’ excellent project of technological innovation” by the Project Committee of Zhejiang Province on April 10, 1997.“HANZHUTING”(mifepristone tablets) was awarded as "Famous Brand Product in Zhejiang Province".

The products--- Ciprofloxac Hydrochloride , Naproxen, ,Mifepristone ,Prednisone and Norfloxacin Capsules were awarded as" High Quality medicines" of 1997 on November 5, 1997, among which naproxen obtained this title for three consecutive years, and won a bronze medal issued by the Pharmaceutical bureau of Zhejiang province.

The API---Vecuronium Bromide was approved as CGMP compliance in its production process by FDA on February 16, 1998.

Vecuronium Bromide and its injectable formulation were listed in the “National Torch Project 2002”, and also were awarded as the “Second Award of Scientific and Technological Progress in Zhejiang Province”. " Xianlin", an injectalble formulation of Vecuronium Bromide, was conferred as " Famous Brand Product" in Taizhou District.

Prenisolone ,Dexamehtasone Acetate and its formulation of tablets were evaluated as the “province-class new high-tech products” by the Science and Technology Department of Zhejiang Province.

In 2002, two products, including ST-1435, were ranked on the list of the " National ’15’xxxxx Project".

In 2002, Dexamethasone Acetate, Dexamethasone Sodium Phosphate and Vecuronium Bromide won “scientific and technological progress prize of Taizhou District”.

The most part of pre-clinical study of new medicine---ZXH951 had been finished by 2002; it also was ranked on the list of National High-tech Research & Development Program (863 Program).

A desirable progress has been achieved in the R&D of xxxx. This project was yet ranked on the list of National Torch Program 2002.

In November 2002, Xjpharma was evaluated as “ Technique Center of Enterprise of Zhejiang Province”by Economy and Trade Committee of Zhejiang Province.

In 2002, Xjpharma was evaluated as “Excellent Manufacturer with self-support of Zhejiang Province.

In 2002, Xjpharma won the “Business Credit AAA (Observing Contract and Keeping Credit) of Zhejiang Province”.

In April 2003, Xjpharma was evaluated as “Provincial High-tech R&D Centre” by the Science & Technology Bureau of Zhejiang Province.